Tech Company Inital Public Offerings
Cerulean Pharma IPO
Cerulean Pharma, operating out of Cambridge, debuted as a public company on 4/10/2014.
Transaction Overview
Company Name
Announced On
4/10/2014
Transaction Type
IPO
Amount
$59,500,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Friedman
VP - Bus. Development
Christopher Guiffre
VP - Finance
Karen Roberts
VP - Manufacturing
Marc Wolfgang
VP - R & D
Scott Eliasof
Browse more venture capital transactions:
Prev: 4/10/2014: Spero Therapeutics venture capital transaction
Next: 4/10/2014: Muut venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs